(Q44433830)

2 December 2017

title

Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug (English)

1 reference

2 December 2017

1 reference

https://api.crossref.org/works/10.1007/S00280-003-0580-5

31 December 2023

1 reference

https://api.crossref.org/works/10.1007/S00280-003-0580-5

31 December 2023

5

Jane Trepel

1 reference

2 December 2017

1

Martin J. Edelman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12736763

31 December 2023

author name string

Kenneth Bauer

2

1 reference

2 December 2017

Shyam Khanwani

3

1 reference

2 December 2017

Nancy Tait

4

1 reference

2 December 2017

Judith Karp

6

1 reference

2 December 2017

Noble Nemieboka

7

1 reference

2 December 2017

Eun-Joo Chung

8

1 reference

2 December 2017

David Van Echo

9

1 reference

2 December 2017

Jane Trepel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12736763

31 December 2023

language of work or name

1 reference

12 March 2003

1 reference

Cancer Chemotherapy and Pharmacology

2 December 2017

published in

1 reference

2 December 2017

volume

51

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

439-444

1 reference

https://scigraph.springernature.com/pub.10.1007/s00280-003-0580-5

2 December 2017

exact match

0 references

cites work

Butyric acid: a small fatty acid with diverse biological functions

1

1 reference

https://api.crossref.org/works/10.1007/S00280-003-0580-5

Modulation of cell cycle-related protein expression by sodium butyrate in human non-small cell lung cancer cell lines

31 December 2023

2

1 reference

https://api.crossref.org/works/10.1007/S00280-003-0580-5

Antitumor activity of tributyrin in murine melanoma model.

31 December 2023

5

1 reference

https://api.crossref.org/works/10.1007/S00280-003-0580-5

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

31 December 2023

9

1 reference

https://api.crossref.org/works/10.1007/S00280-003-0580-5

Butyrate as a differentiating agent: pharmacokinetics, analogues and current status

31 December 2023

10

1 reference

https://api.crossref.org/works/10.1007/S00280-003-0580-5

A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders

31 December 2023

12

1 reference

https://api.crossref.org/works/10.1007/S00280-003-0580-5

Cows' milk fat components as potential anticarcinogenic agents

31 December 2023

14

1 reference

https://api.crossref.org/works/10.1007/S00280-003-0580-5

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

31 December 2023

15

1 reference

https://api.crossref.org/works/10.1007/S00280-003-0580-5

Tributyrin plus all-trans-retinoic acid efficiently induces fetal hemoglobin expression in human erythroleukemia cells

31 December 2023

16

1 reference

https://api.crossref.org/works/10.1007/S00280-003-0580-5

Tributyrin enhances the cytotoxic activity of interleukin-2/interleukin-12 stimulated human natural killer cells against LS 174T colon cancer cells in vitro

31 December 2023

17

1 reference

https://api.crossref.org/works/10.1007/S00280-003-0580-5

Activity of pivaloyloxymethyl butyrate, a novel anticancer agent, on primary human tumor colony-forming units.

31 December 2023

18

1 reference

https://api.crossref.org/works/10.1007/S00280-003-0580-5

31 December 2023

Identifiers

0 references

1 reference